Related Experiment Video
Updated: Aug 14, 2026
28:15
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
Mutations predisposing to hereditary nonpolyposis colorectal cancer
P Peltomäki1, A de la Chapelle
1Department of Medical Genetics, Haartman Institute, University of Helsinki, Finland.
Advances in Cancer Research
|January 1, 1997
Summary
Hereditary nonpolyposis colorectal cancer (HNPCC) is linked to mutations in DNA mismatch repair genes. Identifying these mutations aids in understanding cancer development and offers predictive testing for at-risk individuals.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Hereditary nonpolyposis colorectal cancer (HNPCC) is an inherited cancer syndrome.
- Four DNA mismatch repair (MMR) genes are implicated in HNPCC predisposition.
- MMR gene mutations lead to accumulated genomic errors, promoting cancer development.
Purpose of the Study:
- To review the identified MMR genes and mutations associated with HNPCC.
- To discuss the implications of MMR gene mutations in cancer pathogenesis.
- To highlight the role of mutation knowledge in predictive testing and clinical management.
Main Methods:
- Review of scientific literature on HNPCC and DNA mismatch repair genes.
- Analysis of mutation data and genotype-phenotype correlations.
- Discussion of mutation screening challenges and clinical applications.
Main Results:
- Over 70 germline mutations in MMR genes are linked to HNPCC.
- MSH2 and MLH1 genes are most frequently involved, with ethnic variations.
- Most mutations result in truncated, non-functional protein products.
Conclusions:
- Understanding MMR gene mutations is crucial for HNPCC pathogenesis research.
- Mutation screening enables genotype-phenotype correlations and predictive testing.
- Knowledge of mutations facilitates personalized clinical management for HNPCC families.
Related Concept Videos
01:36Mismatch Repair
Overview
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
01:20Mismatch Repair
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...